Novartis AG (NVSEF)
134.53
+0.33
(+0.25%)
USD |
OTCM |
Oct 05, 16:00
Novartis 1 Year Total Returns (Daily) : 8.32% for Oct. 5, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 05, 2026 | 8.32% |
| October 02, 2026 | 9.88% |
| October 01, 2026 | 15.39% |
| September 30, 2026 | 17.53% |
| September 29, 2026 | 19.86% |
| September 28, 2026 | 21.31% |
| September 25, 2026 | 17.41% |
| September 24, 2026 | 18.70% |
| September 23, 2026 | 17.16% |
| September 22, 2026 | 15.19% |
| September 21, 2026 | 16.39% |
| September 18, 2026 | 12.56% |
| September 17, 2026 | 18.27% |
| September 16, 2026 | 18.27% |
| September 15, 2026 | 19.41% |
| September 14, 2026 | 9.97% |
| September 11, 2026 | 12.43% |
| September 10, 2026 | 13.47% |
| September 09, 2026 | 11.81% |
| September 08, 2026 | 32.60% |
| September 04, 2026 | 29.93% |
| September 03, 2026 | 29.93% |
| September 02, 2026 | 23.58% |
| September 01, 2026 | 27.76% |
| August 31, 2026 | 14.30% |
| Date | Value |
|---|---|
| August 28, 2026 | 38.27% |
| August 27, 2026 | 38.27% |
| August 26, 2026 | 38.27% |
| August 25, 2026 | 38.27% |
| August 24, 2026 | 32.94% |
| August 21, 2026 | 28.08% |
| August 20, 2026 | 28.57% |
| August 19, 2026 | 36.49% |
| August 18, 2026 | 27.73% |
| August 17, 2026 | 24.49% |
| August 14, 2026 | 40.85% |
| August 13, 2026 | 40.85% |
| August 12, 2026 | 40.85% |
| August 11, 2026 | 40.85% |
| August 10, 2026 | 36.12% |
| August 07, 2026 | 37.29% |
| August 06, 2026 | 37.29% |
| August 05, 2026 | 39.22% |
| August 04, 2026 | 40.54% |
| August 03, 2026 | 34.94% |
| July 31, 2026 | 40.80% |
| July 30, 2026 | 40.19% |
| July 29, 2026 | 38.91% |
| July 28, 2026 | 33.81% |
| July 27, 2026 | 33.81% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Roche Holding AG | 19.50% |
| Addex Therapeutics Ltd. | -66.30% |
| Oculis Holding AG | -51.28% |
| Sandoz Group AG | 46.47% |
| Galderma Group AG | 9.04% |